Valsartan improves quality of life for patients with heart failure Meeting report 12 February 2013 Pages: 3 - 4
Antibacterial prophylaxis `a cost-saving strategy' for cholangitis Clinical study 12 February 2013 Pages: 5 - 5
Combined Pap/HPV screening for cervical cancer worth the extra cost Clinical study 12 February 2013 Pages: 5 - 5
NSAIDs used frequently in paediatric arthritis in Germany Clinical study 12 February 2013 Pages: 6 - 6
Coronary stenting vs surgery: effects on cost and resource use Clinical study 12 February 2013 Pages: 7 - 7
Gemcitabine alone or in combination with cisplatin cost effective in NSCLC Clinical study 12 February 2013 Pages: 7 - 7
Timely, suitable antibacterial use reduces LOS in patients with CAP Clinical study 12 February 2013 Pages: 7 - 7
CHD outcomes improved with physician-prompting programme Clinical study 12 February 2013 Pages: 8 - 8
Fluticasone propionate + salmeterol cost saving dual therapy in asthma Clinical study 12 February 2013 Pages: 8 - 8
Reflex HPV DNA testing worth it in cervical cancer screening Clinical study 12 February 2013 Pages: 8 - 8
Hospital costs, LOS similar for HIV-negative and -positive patients Clinical study 12 February 2013 Pages: 9 - 9
Varicella vaccination of paediatrics worthwhile in the US Clinical study 12 February 2013 Pages: 9 - 9
Azithromycin QOL effect in acute bronchitis no better than ascorbic acid Clinical study 12 February 2013 Pages: 10 - 10
Inhaled corticosteroids plus salmeterol relieve costs in asthma Clinical study 12 February 2013 Pages: 10 - 10
Counterfeit drug trade in Russia costs pharma industry > $US250m/year News item 12 February 2013 Pages: 11 - 11
Drugs to treat cancer likely to be covered under US Medicare News item 12 February 2013 Pages: 11 - 11
PedsQL: reliable, valid QOL tool for paediatric cancer Clinical study 12 February 2013 Pages: 11 - 11
Sildenafil tops list of lifestyle drugs sold without prescription over the Internet News item 12 February 2013 Pages: 11 - 11
New drug label for OTC drugs comes into effect in the US Media release 12 February 2013 Pages: 12 - 12